HARTFORD, Conn. (AP) — Connecticut is considering imposing a state review whenever prescription drug prices rise beyond a certain threshold.
State Comptroller Kevin Lembo and Rep. Sean Scanlon, both Democrats, unveiled legislation Tuesday that would create such a system. Their bill also requires drug manufacturers and pharmacy benefit managers to disclose information about rebates and deals they’ve negotiated between themselves.
Lembo, who is seeking re-election, says consumers pay “massive, often inexplicable, drug price markups without even realizing it.” He says a state review will determine the rationalization for sudden price spikes.
Under the bill, the state Office of Health Strategy will have the authority to request justification for whenever a drug price increases beyond a 25-percent threshold. Also, state-registered pharmacy benefit managers will have to disclose the amount of rebates they’ve received from manufacturers.
Copyright 2018 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.